The United States Army will be hosting an industry day inthe Hyatt hotel in Newport RI, on October 14, 2011. The purpose of the industry day is to inform pharmaceutical contractors about the BSCAV/Nerve Agent prophylactic contract is to select, develop, and manufacture an FDA-approved drug/biologic to increase survival and decrease incapacitation such that forces can maintain operational effectiveness within acontaminated area following nerve agent exposure, irrespective of nerve agent type. The BSCAV project is indented to provide medical countermeasures against the effects of organophosphorous nerve agent chemical warfare threats. The proponent for this effort is The Medical Identification and Treatment Systems (MITS) Joint Product Management Office of The Chemical Biological Medical Systems (CBMS) Joint Project Management Office of the Joint Program Executive Office for Chemical and Biological Defense (JPEO-CBD).
Registration for the event closes Friday, October 7, 2011 at 5pm EST.
For more information, please see: https://www3.natick.army.mil/bscav.html
